A Real-world study evaluating treatment discontinuation and resource utilization associated with fingolimod and dimethyl fumarate in patients with multiple sclerosis
Latest Information Update: 17 Nov 2016
At a glance
- Drugs Dimethyl fumarate (Primary) ; Fingolimod (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions; Therapeutic Use
- 17 Nov 2016 New trial record